Literature DB >> 25577608

Lower back pain.

Eric R Castillo1, Daniel E Lieberman1.   

Abstract

Entities:  

Year:  2015        PMID: 25577608      PMCID: PMC4315061          DOI: 10.1093/emph/eou034

Source DB:  PubMed          Journal:  Evol Med Public Health        ISSN: 2050-6201


× No keyword cloud information.

Lower back pain

Lower back pain (LBP) is one of the most common and costly medical problems today [1, 2]. Pain is usually transitory and can arise from the intervertebral discs, bones, ligaments and muscles of the spine. Risk factors for LBP include genetic, environmental, psychosocial and biomechanical influences [3]. However, although 85% of LBP cases have no clear etiology, 97% may be due to musculoskeletal issues [4]. Lumbar curvature (lordosis) is one factor that generates shearing between adjacent vertebrae and at intervertebral joints. People with high degrees of lumbar lordosis, including pregnant women, can experience excessive shearing (Fshear) and compression (Fcompression) forces between lumbar vertebrae, most often between the last lumbar and the sacrum [3, 5]. In addition to other factors, including age-related spinal degeneration, high levels of Fshear and Fcompression can lead to painful muscle strain, joint capsule pain, disc herniation, inflammation (spondylitis), bone degeneration (spondylolysis) and vertebral displacement (spondylolisthesis) [3-5].

Evolutionary perspectives

Mechanically induced LBP is often thought be a consequence of trade-offs in the spine due to selection for bipedalism from a quadrupedal ancestor. According to this hypothesis, the costs of increased Fshear due to lordosis were offset by the benefits of positioning the upper body’s center of mass over the hips, stabilizing the trunk and decreasing the costs of upright posture. The only two known complete lumbar spines from early hominins show the same sexually dimorphic pattern present in modern humans, with males having fewer wedge-shaped, lordotic vertebrae than females [5]. More fossils are needed, but this suggests selection for decreased Fshear in pregnant hominin females who exaggerate lordosis to cope with increased fetal mass. Another hypothesis is that some cases of LBP are the result of a recent mismatch, in which the modern human spine is poorly adapted to recent environmental conditions. Since hominins prior to the post-industrial era were very active [6], low levels of physical activity and abnormal spinal loading may result in weak, unstable back tissues and increased risk of pain and injury. Support for this comes from evidence that decreased back muscle strength and endurance strongly correlate with LBP [3]. In addition, novel behaviors that lessen loading, such as sleeping on soft mattresses and prolonged sitting in chairs, may be associated with higher LBP rates [7, 8]. Also, active farmers from low-income countries may have two to four times lower rates of LBP than sedentary, urban people from high-income countries, though demographic factors (e.g. age) may bias these findings [9].

Future implications

If some cases of LBP are the result of a recent mismatch, LBP rates may be on the rise as sedentary behaviors increase. This may also suggest that trunk strengthening and endurance exercises can help treat and prevent some cases of LBP. However, the mismatch hypothesis has been poorly tested. More biomechanical research is needed to explore the relationship between novel types of spinal loading (e.g. sitting in chairs, using soft mattresses) and LBP. Detailed comparative studies of LBP rates around the world are necessary to test the hypothesis, comparing age-matched groups with different activity levels and subsistence patterns, such as hunter–gatherers and non-industrial populations.
  6 in total

Review 1.  Low back pain.

Authors:  R A Deyo; J N Weinstein
Journal:  N Engl J Med       Date:  2001-02-01       Impact factor: 91.245

2.  Estimates and patterns of direct health care expenditures among individuals with back pain in the United States.

Authors:  Xuemei Luo; Ricardo Pietrobon; Shawn X Sun; Gordon G Liu; Lloyd Hey
Journal:  Spine (Phila Pa 1976)       Date:  2004-01-01       Impact factor: 3.468

3.  Fetal load and the evolution of lumbar lordosis in bipedal hominins.

Authors:  Katherine K Whitcome; Liza J Shapiro; Daniel E Lieberman
Journal:  Nature       Date:  2007-12-13       Impact factor: 49.962

Review 4.  The epidemiology of low back pain in the rest of the world. A review of surveys in low- and middle-income countries.

Authors:  E Volinn
Journal:  Spine (Phila Pa 1976)       Date:  1997-08-01       Impact factor: 3.468

Review 5.  The Epidemiology of low back pain.

Authors:  D Hoy; P Brooks; F Blyth; R Buchbinder
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-12       Impact factor: 4.098

6.  Bed design and its effect on chronic low back pain--a limited controlled trial.

Authors:  S R Garfin; S A Pye
Journal:  Pain       Date:  1981-02       Impact factor: 6.961

  6 in total
  3 in total

1.  Duhuo Jisheng Decoction inhibits SDF-1-induced inflammation and matrix degradation in human degenerative nucleus pulposus cells in vitro through the CXCR4/NF-κB pathway.

Authors:  Zong-Chao Liu; Zhen-Long Wang; Chen-Yi Huang; Zhi-Jiang Fu; Yong Liu; Zhang-Chao Wei; Shi-Gui Liu; Chuan Ma; Jie-Liang Shen; Dayue Darrel Duan
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

2.  Organization of the fascia and aponeurosis in the lumbar paraspinal compartment.

Authors:  Maud Creze; Marc Soubeyrand; Krystel Nyangoh Timoh; Olivier Gagey
Journal:  Surg Radiol Anat       Date:  2018-08-31       Impact factor: 1.246

3.  Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Liuwei Dihuang Decoction Against Intervertebral Disc Degeneration.

Authors:  Huihao Zhang; Sai Yao; Zhiguo Zhang; Chengcong Zhou; Fangda Fu; Yishan Bian; Huan Luo; Yan Li; Shuxin Yan; Yuying Ge; Yuying Chen; Kunyu Zhan; Yanzhi Ge; Zuxiang Chen; Ming Yue; Xiaofeng Li; Weibin Du; Hongting Jin; Peijian Tong; Hongfeng Ruan; Chengliang Wu
Journal:  Drug Des Devel Ther       Date:  2021-12-02       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.